BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


SEARCH JOBS










 Company News
Eureka Therapeutics And Boehringer Ingelheim Announce A Collaboration To Identify Next Generation Antibodies For Cancer Treatment 5/22/2015 8:52:26 AM
Boehringer Ingelheim Release: New Data Show Benefit Of Tiotropium/Olodaterol Respimat From The Start Of COPD Maintenance Therapy1,2,3 5/20/2015 11:36:24 AM
Boehringer Ingelheim Release: New Data Analyses On Investigational Tiotropium/Olodaterol Respimat Showed Greater Lung Function Improvement Compared To Tiotropium And Olodaterol Alone 5/20/2015 11:05:32 AM
Boehringer Ingelheim Acquires Pharmaxis (PXS.AX)’ Phase 1 Anti-Inflammatory Drug Candidate 5/18/2015 11:08:03 AM
Boehringer Ingelheim Presents New Data And Analyses Reinforcing The Safety And Efficacy Of OFEV (nintedanib) Capsules 5/18/2015 6:46:15 AM
Pharmaxis (PXS.AX) Shares Catapult on $750 Million Liver Drug Sale to Boehringer Ingelheim 5/18/2015 6:09:16 AM
Boehringer Ingelheim Showcases Expanding Presence In Lung Cancer At ASCO With New Data Including Presentation Of Gilotrif (Afatinib) Overall Survival Results For Squamous Cell Carcinoma Of The Lung 5/14/2015 11:23:26 AM
Boehringer Ingelheim Release: First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation 5/14/2015 10:53:47 AM
Boehringer Ingelheim Release: First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation 5/13/2015 1:32:40 PM
Boehringer Ingelheim To Present 29 Abstracts At The Annual American Thoracic Society International Conference 5/5/2015 10:28:05 AM
12345678910...